Inter-organ cross talk in heart failure: A multisite biomarker sampling study (ACTRN12621001725853)

Non fasting blood samples are collected during the patients clinically indicated right heart catheterisation procedure. Blood is taken from the coronary sinus, pulmonary, hepatic and renal vein and from an arterial site. An echocardiogram is performed if the patient has not had one within the past 3 months. A 6 WMT and QOL questionnaires, ECG may also be performed.

Trial phase

Biobank

Trial participation type

This trial is for clinical research of something other than a drug or device.

Principal investigator

Prof David Kaye

Key inclusion data

Inclusion: Diagnosis of heart failure (HFpEF or HFpEF) NYHAFC II-IV, ischaemic or non ischaemic aetiology, stable HF therapy for 1 month. Exclusion: prior heart transplant, complex congenital heart disease, unstable heart failure, pregnant woman.